EWING, WILLIAM, R.,WANG, YUFENG,DILGER, ANDREW, K.,FANG, TIANAN,PINTO, DONALD, J.P.,WEXLER, RUTH, R.,ZHU, YEHENG,PABBISETTY, KUMAR BALASHANMUGA,DE LUCCA, INDAWATI,ORWAT, MICHAEL, J.,SMITH II, LEON, M.
申请号：
RSP20180033
公开号：
RS56785B1
申请日:
2015.01.30
申请国别(地区):
RS
年份:
2018
代理人:
摘要：
or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
